Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis

Table 1 Baseline clinical characteristics for the ABT-116, carprofen, tramadol, and placebo treatment groups

	ABT-116	Carprofen	Tramadol	Placebo
	(n = 13)	(n = 12)	(n = 12)	(n = 12)
Body weight (kg)	34.9 ± 6.0	34.2 ± 6.9	34.9 ± 9.9	34.0 ± 8.4
Age (years)	6.0 ± 4.1	8.6 ± 3.6	9.2 ± 3.2	9.5 ± 4.2
Gender	SF – 8	SF – 6	SF – 7	SF – 8
	NM - 5	NM - 6	F - 1	NM – 3
			NM - 4	M - 1
Clinical Severity	2 (1, 3)	1.5 (1, 3)	2, (1, 3)	2 (1, 3)

Note: All values represent mean ± standard deviation, except for clinical severity, which is reported as median (range). n – sample number. SF – ovariohysterectomized female; F – female; NM – castrated male; M – male. At the start of the trial (Day 1), dogs were graded for clinical severity of lameness and pain (normal – 0; mild – 1; moderate −2; and severe - 3), and orthopaedic physical examination was performed.

ISSN: 1746-6148